Subjects: Patients were diagnosed chronic myeloid leukemia in chronic phase with BCR / ABL fusion gene or Philadelphia chromosome and resistance or intolerance with Imatinib mesylate from 10/2014 to 06/2015 in Blood Transfusion and Hematology Hospital, Ho Chi MinhCity.